Myocardial injury following transcatheter aortic valve implantation: Insights from delayed-enhancement cardiovascular magnetic resonance

EuroIntervention

Volumn 11, Issue 2, 2015, Pages 205-213

  Ribeiro, Henrique B ^a   Larose, Éric ^a   De La Paz Ricapito, Maria ^a   Le Ven, Florent ^a   Nombela Franco, Luis ^a   Urena, Marina ^a   Allende, Ricardo ^a   Amat Santos, Ignacio ^a   Dahou, Abdellaziz ^a   Capoulade, Romain ^a   Clavel, Marie Annick ^a   Mohammadi, Siamak ^a   Paradis, Jean Michel ^a   De Larochellière, Robert ^a   Doyle, Daniel ^a   Dumont, Éric ^a   Pibarot, Philippe ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Cardiac biomarkers; Cardiac magnetic resonance imaging; Late gadoliniumenhancement; Myocardial injury; Transcatheter aortic valve implantation

Indexed keywords

CREATINE KINASE MB; GADOLINIUM PENTETATE; TROPONIN T;

AGED; AORTA VALVE STENOSIS; ARTICLE; BALLOON DILATATION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICULAR APEX; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART VENTRICLE; HUMAN; HYPOTENSION; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCUTANEOUS AORTIC VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC VALVE STENOSIS; HEART; HEART CATHETERIZATION; HEART INJURY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; HEART; HEART INJURIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84933531819     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV11I2A39     Document Type: Article

References (23)

1. Rodes-Cabau J, Gutierrez M, Bagur R, De Larochelliere R, Doyle D, Cote M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57:1988-99.
2. Yong ZY, Wiegerinck EM, Boerlage-van Dijk K, Koch KT, Vis MM, Bouma BJ, Henriques JP, Cocchieri R, Piek JJ, de Mol BA, Baan J Jr. Predictors and prognostic value of myocardial injury dur-ing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2012;5:415-23.
3. Carrabba N, Valenti R, Migliorini A, Vergara R, Parodi G, Antoniucci D. Prognostic value of myocardial injury following transcatheter aortic valve implantation. Am J Cardiol. 2013;111:1475-81.
4. Barbash IM, Dvir D, Ben-Dor I, Badr S, Okubagzi P, Torguson R, Corso PJ, Xue Z, Satler LF, Pichard AD, Waksman R. Prevalence and effect of myocardial injury after transcatheter aortic valve replacement. Am J Cardiol. 2013;111:1337-43.
5. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-54.
6. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular mag-netic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol. 2004;43:2253-9.
7. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after per-cutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular mag-netic resonance imaging. Circulation. 2005;111:1027-32.
8. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free sur-vival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733-43.
9. Rodes-Cabau J. Transcatheter aortic valve implantation: cur-rent and future approaches. Nat Rev Cardiol. 2012;9:15-29.
10. Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, McCann GP, Greenwood JP. Assessment of valve haemodynamics, reverse ventricular remodelling and myo-cardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99:1185-91.
11. Khatri PJ, Webb JG, Rodes-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC, Ko DT. Adverse effects asso-ciated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013;158: 35-46.
12. Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F, Serruys PW, Virmani R, de Jaegere PP. Histopathology of embolic debris captured during transcatheter aortic valve replace-ment. Circulation. 2013;127:2194-201.
13. Prasad A, Herrmann J. Myocardial infarction due to percuta-neous coronary intervention. N Engl J Med. 2011;364:453-64.
14. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. AJR Am J Roentgenol. 2006;187: W630-5.
15. Barbash IM, Saikus CE, Faranesh AZ, Ratnayaka K, Kocaturk O, Chen MY, Bell JA, Virmani R, Schenke WH, Hansen MS, Slack MC, Lederman RJ. Direct percutaneous left ven-tricular access and port closure: pre-clinical feasibility. JACC Cardiovasc Interv. 2011;4:1318-25.
16. Botha P, Nagarajan DV, Lewis PS, Dunning J. Can cardiac troponins be used to diagnose a perioperative myocardial infarc-tion post cardiac surgery? Interact Cardiovasc Thorac Surg. 2004;3:442-9.
17. Zemrak F, Petersen SE. Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis. 2011;54:215-29.
18. Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, Tarasoutchi F, Grinberg M, Rochitte CE. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56: 278-87.
19. Barbash IM, Dvir D, Ben-Dor I, Corso PJ, Goldstein SA, Wang Z, Bond E, Okubagzi PG, Satler LF, Pichard AD, Waksman R. Impact of transapical aortic valve replacement on apical wall motion. J Am Soc Echocardiogr. 2013;26:255-60.
20. van der Boon RM, Marcheix B, Tchetche D, Chieffo A, Van Mieghem NM, Dumonteil N, Vahdat O, Maisano F, Serruys PW, Kappetein AP, Fajadet J, Colombo A, Carrie D, van Domburg RT, de Jaegere PP. Transapical versus transfemoral aortic valve implan-tation: a multicenter collaborative study. Ann Thorac Surg. 2014;97:22-8.
21. Iung B, Laouenan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Vahanian A, Gilard M; FRANCE-2 Investigators. Predictive factors of early mortality after transcathe-ter aortic valve implantation: individual risk assessment using a simple score. Heart. 2014;100:1016-23.
22. Blackman DJ, Baxter PD, Gale CP, Moat NE, Maccarthy PA, Hildick-Smith D, Trivedi U, Cunningham D, DE Belder MA, Ludman PF; National Institute for Cardiovascular Outcomes Research (NICOR). Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. J Interv Cardiol. 2014;27:86-95.
23. Li X, Kong M, Jiang D, Dong A. Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg. 2013;8:168.